Analysts think PGEN stock price could increase by 282%
Feb 07, 2025, 12:25 PM
15.63%
What does PGEN do
Precigen, a biotechnology company headquartered in Germantown, Maryland, focuses on synthetic biology technologies and develops therapies for urgent diseases. Founded in 2013, it operates through Biopharmaceuticals and Exemplar segments.
5 analysts think PGEN stock price will increase by 282.50%. The current median analyst target is $6.12 compared to a current stock price of $1.60. The lowest analysts target is $5.05 and the highest analyst target is $7.35.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
